Skip to Content

MFS Lifetime 2020 R1 MFLEX

Analyst rating as of
Premium

Morningstar’s Analysis

Will MFLEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A beneficiary of the broader firm’s strength.

Associate Analyst

Summary

| |

MFS Lifetime target-date series benefits from the firm’s well-regarded fund lineup, but a risky glide path and modest supporting resources mute its appeal. Most share classes receive a Morningstar Analyst Rating of Neutral, while the pricier R1, B, and C share classes are rated Negative.

Unlock our full analysis with Morningstar Premium